134 results
6-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
9 Aug 06
Adherex Reports Second Quarter 2006 Financial Results
12:00am
-1 and the Phase I clinical studies for eniluracil partially offset by decreased spending for other operating activities.
The net loss for the six … related to our expanding clinical trial program partially offset by a $0.2 million decrease in G&A as compared to the prior year.
Cash and cash
6-K
EX-99.1
t2m423b zbb67
12 Aug 05
Adherex Reports Second Quarter 2005 Financial Results
12:00am
6-K
EX-99.3
470dmg 7cbqwr
9 Aug 06
Adherex Reports Second Quarter 2006 Financial Results
12:00am
8-K
3yzrukvaz2ur 96v4
11 Dec 08
Adherex Receives AMEX Delisting Notice
12:00am
8-K
EX-99.1
3blajm y6y3r1cjdso
13 May 08
Adherex Reports First Quarter 2008 Financial Results
12:00am
8-K
EX-10.22
fjf3d52 i7v
11 Dec 08
Adherex Receives AMEX Delisting Notice
12:00am
8-K
EX-99.1
mp3irsfq t4
11 Dec 08
Adherex Receives AMEX Delisting Notice
12:00am
8-K
EX-99.1
o5cirtic
8 Nov 07
Adherex Reports Third Quarter 2007 Financial Results
12:00am